Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today ...
Most recently in July, we completed a $5 million public offering. We continue to explore the possible effects of REVTx-99b for the treatment of allergies. Data from our preclinical and Phase 2 viral ...
The spectrum of special purpose acquisition company mergers encompasses all deal sizes. While multibillion-dollar mergers have defined the space in 2021, Revelation Biosciences is joining with Petra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback